Article Details
Retrieved on: 2022-04-24 14:32:40
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
CureVac and GSK's second-generation vaccine candidate targeting two recent COVID-19 variants has been shown to be highly effective in preclinical ...
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here